Below are resources gathered from the College, the Government of New Brunswick, the New Brunswick Pharmacists Association, Health Canada, and other stakeholders. 

The COVID-19 situation is evolving rapidly. The guidance provided on this page is intended to support pharmacy professionals with foundational information and advice. This page will be regularly updated on an ongoing basis.

NBCP Guidance and Resources


- Message from the Registrar: If staff get sick & Business continuity (Updated April 2)
- NBCP & NBPA Message: If staff get sick (April 1)
- Signage: Do not enter the pharmacy if exhibiting symptoms of COVID-19
- NBCP Office Operations (Updated June 19)
- NBCP Guidance: COVID-19 & Provision of pharmacy services to long-term care facilities (Updated May 29)
- NBCP Guidance: COVID-19 & Business continuity planning (May 7)
- NBCP Guidance: COVID-19 & Delivery requirements (May 1)
- COVID-19 Notice of Temporary Closure Form (June 9)

Medication Management and Pharmacy Practice

- NBCP Directive: 30-Day Supply of medication (Revoked by Mandatory Order of the Government of New Brunswick - April 23)
- NBCP Guidance: COVID-19 & Dispensing appropriately (antimalarials, etc.) (March 23)
- NBCP Guidance: COVID-19 & Provision of methadone and other substances (Updated May 29)
- NBCP Guidance: COVID-19 & Administration of injections (Updated May 28)
- NBCP Guidance: COVID-19 & Therapeutic substitution in times of medication shortages (Updated June 19)
- NBCP Guidance: COVID-19 & Return of medication to inventory for use (May 29)

Emergency Registration

- Emergency Registration and Licensure
- New Graduates 

Government of New Brunswick Resources 

- Novel Coronavirus (COVID-19) Guidance for Community Pharmacies
- Bulletins for Health Care Professionals 
- NB Drug Plans Special Bulletins 

New Brunswick Pharmacists Association Resources

- NBPA Suggested resources for pharmacies - physical distancing and supply vendors 
- NBPA COVID-19 web page
- NBPA news page

Health Canada Resources 

- Exemptions for prescriptions of controlled substances under the Controlled Drugs and Substances Act (CDSA) and its Regulations 
- Requirements for Chain Signatures in light of COVID-19
- No scientific evidence that ibuprofen worsens COVID-19 symptoms 
- Health Canada Application and Notification Form for Exceptional Release of Disinfectant ans Sanitizing Products  

Public Health Agency Resources

- COVID-19: What Health Professionals Should Know
- COVID-19 Travel Guidance

Canadian Pharmacists Association Resources

- Practice Resources
- Drug Therapy Resources
- The Daily: CPhA's COVID-19 Update to the Pharmacy Community
- Webinars
- Guidelines for protecting the front line 

Other Stakeholders

- A Pharmacist's Guide to Pandemic Preparedness (Ontario Pharmacists Association)
- Psychosocial Support for Health Professionals (British Columbia)
- H2 receptor antagonist shortages (MedSask)